MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

    F. Hopfner, S. Müller, D. Steppat, J. Miller, N. Schmidt, K.P. Wandinger, F. Leypoldt, D. Berg, A. Franke, W. Lieb, L. Tittmann, M. Balzer-Geldsetzer, S. Baudrexel, R. Dodel, R. Hilker-Roggendorf, E. Kalbe, J. Kassubek, T. Klockgether, I. Liepelt-Scarfone, B. Mollenhauer, P. Neuser, K. Reetz, O. Riedel, C. Schulte, J. Schulz, A. Spottke, A. Storch, C. Trenkwalder, G. Deuschl, G. Kuhlenbäumer (Kiel, Germany)

    Objective: We measured NMDA antibodies in a large, well phenotyped sample of Parkinson patients without and with cognitive impairment (n = 297) and controls (n…
  • 2018 International Congress

    Tetrahydroisoquinoline Molecule Identified in Traditional Ayurveda Medicine Modulates Inflammation in MPTP Mice

    R. Banerjee, R. Paidi, P. Jaisankar, K. Mohanakumar, S. Biswas (Kolkata, India)

    Objective: Potential ‘Anti-parkinsonian’ activity of a tetrahydroisoquinoline (TIQ) molecule of traditional ‘Ayurveda’ medicine was tested in a preclinical MPTP mice model for Parkinson’s disease (PD).…
  • 2018 International Congress

    Association between serum Vitamin D levels and Parkinson’s disease: A systematic review and meta-analysis

    XY. Luo, R. Ou, HF. Shang (Chengdu, China)

    Objective: The aim of this systematic review and meta-analysis was to evaluate the association between serum vitamin D levels and the risk and severity of…
  • 2018 International Congress

    Alpha-synuclein oligomer and rotenone treatments injury the dopaminergic neuron via inhibiting the expression of gene SEMA6D

    X. Yingyu (Guangzhou, China)

    Objective: To investigate the expression of Semaphorin6D (SEMA6D) and its interaction with Plexin-A1 in cellular Parkinson's disease(PD) models induced by α-synuclein and rotenone. Background: In…
  • 2018 International Congress

    Functional Balance and Neuromuscular Strength Difficulties Like Fracture Predictors in a Parkinsonian Population

    L. Leandro, C. Moreira, H. Teive (Curitiba, Brazil)

    Objective: To evaluate the strength and function of the hip flexor muscles and knee extensors of elderly patients with Parkinson's disease (PD) to know possible…
  • 2018 International Congress

    Zonisamide improves parkinsonism in DLB patients: A randomized phase 3 trial

    M. Murata, T. Odawara, K. Hasegawa, R. Kajiwara, H. Takeuchi, M. Tagawa, K. Kosaka (Kodaira, Japan)

    Objective: To verify the efficacy and safety of zonisamide (ZNS) for parkinsonism in patients with dementia with Lewy bodies (DLB). Background: DLB parkinsonism is responsive…
  • 2018 International Congress

    A framework to facilitate competence in practice for Parkinson’s Disease Nurse Specialists in the United Kingdom

    H. Martin, J. Price, L. Ebenezer (Coventry, United Kingdom)

    Objective: To determine if the current Parkinson's Disease Nurse Specialist (PDNS) competency framework 2nd Edition 2008 (1) for nurses working in the management of Parkinson's…
  • 2018 International Congress

    Diagnostic potential of automated middle cerebellar peduncle volumetry in variants of multiple system atrophy

    F. Krismer, K. Seppi, T. Potrusil, R. Steiger, I. Zucal, G. Göbel, G. Wenning, E. Gizewski, W. Poewe, C. Scherfler (Innsbruck, Austria)

    Objective: To include probabilistic information on the location of the middle cerebellar peduncle (MCP) into an existing subcortical segmentation atlas and to evaluate the diagnostic…
  • 2018 International Congress

    Efficacy and safety of safinamide as a levodopa adjunct in patients with parkinson disease and motor fluctuations: A systematic review of randomized controlled trials

    S. Hussain, A. Najmi (New Delhi, India)

    Objective: To assess the efficacy and safety of safinamide as an add-on therapy to levodopa in Parkinson patients. Background: Long-term use of levodopa is associated…
  • 2018 International Congress

    Inhibition of HDAC4 attenuates rotenone-induced abnormal increase of α-synuclein levels and affects autophagic flux in human dopaminergic SH-SY5Y cells

    L. Wang, L. Liu, T. Wang (Wuhan, China)

    Objective: To explore the effects of selective inhibition of HDAC4, on levels of α-syn and autophagy-related proteins in PD. To discuss the mechanism for the…
  • « Previous Page
  • 1
  • …
  • 219
  • 220
  • 221
  • 222
  • 223
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley